• The Supreme Cannabis Company’s five-year partnership with KKE Canada will include brand management and cultivation consulting
• Deal marks the international expansion of popular Khalifa Kush premium brand
• Agreement builds on Supreme Cannabis’ development of 342,000-square-foot facility
• Supreme Cannabis’ 7ACRES subsidiary recently received ‘Brand of the Year’ honors from 2018 Canadian Cannabis Awards

Premium cannabis brand The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) is building on the successes of an expansion and marketing effort that brought in a 229 percent year-over-year sales growth during the past year, thanks largely to its high-quality 7ACRES brand. The company announced this month that it will develop and launch an additional lineup of premium products in conjunction with Khalifa Kush Enterprises Canada ULC (“KKE Canada”).

The products are expected to include pre-rolls, extracts, capsules and cannabis oils to be sold by Supreme Cannabis under the KKE brand, based on KKE’s flagship “Khalifa Kush” strain established in the United States market, according to a December 6 news release (http://ibn.fm/GhqtX).

“With the idea for ‘Kush and Orange Juice’ being created in Toronto, it’s the perfect start for the international expansion of Khalifa Kush. My team and I have spent the past year finding a partner that shares our vision, values and passion for cannabis,” KKE principal Wiz Khalifa stated in the release. “The team at Supreme Cannabis understands the importance of high quality cannabis and how to produce high quality cannabis at scale. I am very excited to be working with them.”

The new premium cannabis brand will be offered in Canada and some additional international markets, excluding the United States. Under the terms of the five-year partnership, KKE Canada will provide Supreme Cannabis with consulting services on brand management and cultivation, including cannabis strain selection and consumer education services.

During the course of the renewable five-year partnership, Supreme Cannabis will have exclusive right to commercialize cannabis products under the KKE brand internationally (excluding the United States) for three years, subject to market approval by KKE and a legal framework in which to operate.

KKE Canada will receive more than 5.7 million common shares of Supreme Cannabis and an initial cash payment of C$1 million, followed by annual royalty payments based on the sale of products developed under the partnership.

“Wiz is a globally-recognized cannabis taste maker and connoisseur,” Supreme Cannabis Founding President John Fowler stated. “KKE has had incredible success in U.S. adult-use markets, establishing a brand that is synonymous with ultra-premium quality, based on world-leading genetics… We’re excited to be working with KKE Canada to build another brand with the same commitment to quality (as 7ACRES) to continue the premiumization of our brand portfolio.”

7ACRES flower is focused on pleasing three primary senses: aroma, visual appeal and flavor, according to Fowler. It is cultivated in a 342,000-square-foot facility that is building toward an annual output of 50,000 kilograms of capacity by the new year. The company has also reached an agreement to acquire communications firm Bayfield Strategy, Inc., which is expected to help with brand marketing (http://ibn.fm/2vzEu). The 2018 Canadian Cannabis Awards presented by Lift & Co. (TSX.V: LIFT) recently honored 7ACRES as the ‘Brand of the Year’ in its fifth annual proceedings (http://ibn.fm/EVXQy).

For more information, visit the company’s website at www.Supreme.ca

• Direct sales industry includes a record 20.5 million involved individuals, promising great potential for entrepreneurs
• Sharing Services, Inc. empowers its team of ‘Elepreneurs’ with mentorship and support
• The company’s Blue Ocean Strategy seeks to set the company apart from the competition

Sharing Services, Inc. (OTCQB: SHRV), a diversified holdings company committed to redefining how entrepreneurs succeed, is reshaping the methodology and strategy inside the direct sales industry.

In an age when many are saying goodbye to the local department store in lieu of more personalized shopping done from the ease of their home computer screens, the direct selling industry promises great potential for entrepreneurs. In 2016, the industry saw a record 20.5 million people involved in direct sales, and that same year’s direct retail sales earnings estimate of $35.54 billion is the second highest in the industry’s history (http://ibn.fm/jkeP4).

Through its Blue Ocean Strategy, Sharing Services, Inc. seeks to redefine the direct selling methodology. Its three pronged approach includes supporting its team of home-based entrepreneurs (called ‘Elepreneurs’) by “utilizing the direct selling channel to generate 100% organic growth,” and cultivating as many new business leaders as possible (http://ibn.fm/8Vq8g). By emphasizing home-based entrepreneurial businesses, Sharing Services, Inc. is creating new factors to its industry that have never been offered, including flexibility and new product offerings, thus innovating the market.

SHRV’s Blue Ocean Strategy alludes to a book by two Harvard Business School professors, titled ‘Blue Ocean Strategy: How to Create Uncontested Market Space and Make Competition Irrelevant’. By improving how business is done in its industry, a company can “swim” away from a bloody “red ocean” to discover a non-competitive ocean, in effect claiming the “waters to itself” (http://ibn.fm/QOKZF). Incidentally, Sharing Services, Inc. is constantly expanding its team of Elepreneurs, as it has added roughly 10,000 independent sales representatives in the last few months alone.

One benefit of direct sales to the customer is a more personalized sales experience. Customers are able to receive “personal demonstration and explanation of products, home delivery,” and a greater emphasis on satisfaction guarantee (http://ibn.fm/RUFGv). Smaller entrepreneurial businesses have a larger investment in their customers’ happiness than do large box stores, so they more often take strides to ensure that the overall buying experience is a positive one to ensure that customers return.

Sharing Services, Inc. embraces this paradigm shift by empowering its entrepreneurs through training and mentorship. It is led by a team of businesspeople with decades of experience. The company’s chairman, Robert Oblon, boasts over 22 years in the online travel industry and many years observing a variety of business models. His experiences observing varying business concepts ultimately led to the company’s emphasis on Elepreneurs. Finding that individuals thrive from positive selling experiences with friendly people willing to add a personalized touch, Oblon encourages his team to consider the role that positive psychology and personal development have in direct sales.

Looking ahead, the company’s growth plan includes international expansion by the end of the fourth quarter of 2018.

For more information, visit the company’s website at www.SHRVInc.com

• REFG’s Go delivers a compliant cashless and digital world for legalized cannabis transactions by dispensaries and merchants; retailers and consumers can sign up for Go online
• REFG is a hemp grower that owns SpeedyGrow, licensed in Colorado; it has established itself as a leader in payment processing by handling some 60 million transactions monthly
• The company’s goal is transactional safety and accuracy; it operates within Financial Crimes Enforcement Network (FinCEN) guidelines and offers a transparent and approved environment

Medical Cannabis Payment Solutions’ (OTC: REFG) ‘Go’ is a processing system which offers cannabis dispensaries, merchants and customers a digital payment program that ensures the safety and accuracy of legalized marijuana transactions (www.PayWithGo.com).

REFG is active in the industry as both a payment processor and hemp grower, as a growing number of U.S. states have legalized cannabis and Canada recently approved its use throughout the country (http://ibn.fm/fsh2N). Medical marijuana is now legal in 33 states plus D.C., and 10 states and D.C. have legalized both medical and recreational marijuana (http://ibn.fm/tzkMf). That bodes well for REFG’s activity in the cannabis industry.

REFG’s Go offers legalized cannabis dispensaries and merchants safety, accuracy and easy online sign-up. It is now available to the entire cannabis market. In addition to creating a cashless environment, Go can handle all payments necessary for a small business retailer, such as payroll and vendor disbursements, accounts payable and any other invoices.

Go is capable of processing cryptocurrency payments. The customer or patient can also pay directly from a bank account without requiring cash. REFG, in addition to processing legalized cannabis transactions through Go, is directly involved in growing and processing hemp. A Nevada-based company, it earlier acquired SpeedyGrow, a Wyoming-based firm licensed to grow and process hemp in Colorado (http://ibn.fm/NNMCi).

For more information, visit the company’s website at www.PayWithGo.com

• Flagship Irgon Lithium Mine Project recently identified additional significant spodumene mineralization
• Global lithium-ion battery market forecast to reach $71 billion by 2025
• Worldwide sales of EVs expected to almost quadruple to 4.5 million units by 2020

An undeniable opportunity exists when referring to the Irgon Lithium Mine Project, wholly owned by Vancouver-based QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ). As part of QMC’s ongoing exploration and development of the Irgon Project, located in southern Manitoba’s bountiful Cat Lake-Winnipeg River Pegmatite Field (http://ibn.fm/mDEzR), the company’s geotechnical field crews recently identified additional significant spodumene mineralization. This discovery is a significant one, since spodumene mineralization is known as being the primary source of hard-rock lithium. Pegmatites hosting spodumene mineralization may contain large amounts of lithium and, in addition, can host other rare-element-bearing minerals (http://ibn.fm/Umu8P).

Lithium is the main ingredient in the lithium-ion batteries used for energy storage and power provisioning. The global appetite for electric vehicles and the rise of modern devices that rely on lithium-ion batteries are expected to drive the lithium-ion battery market to reach $71 billion by 2025, according to a report by Research and Markets (http://ibn.fm/orEax). Almost all computer electronics, smartphones, tablets and other consumer electronic devices are powered by the lithium-ion battery; however, an article in Bloomberg states (http://ibn.fm/gTTEr) that it is the electric/hybrid vehicle market that is projected to require massive amounts of lithium. “Benchmark Minerals Intelligence, a research and data firm, projects demand to rise from about 220,000 tonnes of lithium-carbonate equivalent last year to more than 900,000 in 2025 and around 2 million by the early 2030s,” the article reads.

QMC has invested two years exploring the potential of the Irgon Lithium Mine Property and is working toward updating the historic 1950s resource estimate (1.2 MT at 1.51 percent Li2O). Channel sampling on the Irgon Dike returned results of 1.73 percent lithium-oxide over 14 meters (45.9 feet), which are higher than the historical numbers. Sampling elsewhere on additional targets in the area has produced concentrations of over 1.90 percent lithium-oxide and one that returned 2.62 percent (http://ibn.fm/cbqrz).

Hard rock mining of spodumene as a source for lithium has distinct advantages over reaping elemental lithium from brines, since only highly concentrated brines produce lithium economically and the process to extract the lithium is glacial. The company states (http://ibn.fm/cJL9f) that once the initial exploration phase has been completed on hard rock lithium pegmatites, such as at its Irgon Project, hard rock pegmatite deposits are faster to mine and production is more reliable. QMC is nearing the final stage of this exploration phase and approaching the point at which an updated NI 43-101 can be filed, which will likely lead the company closer to its goal of actively mining the Irgon Lithium Mine Property.

For more information, visit the company’s website at www.QMCMinerals.com

• LXRP is putting its growth plan into effect, adding a new corporate controller, a head of its legal division and more office staff; in 2019, it will also be increasing its lab personnel
• As a result of the latest positions created, the company is issuing 240,000 new stock options with an exercise price of $1.06 that will vest as to 80,000 per year until April 15, 2021
• LXRP has a growing IP portfolio of 10 patents granted in the U.S. and Australia; it has filed for more than 50 patents worldwide across 10 patent families

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a drug delivery platform innovator, has announced aggressive growth plans, including the addition of key personnel, a special focus on its lab R&D activities in 2019 and the issue of new stock options.

It has added a new corporate controller, a head of its legal division and additional office staff. In addition, LXRP anticipates adding more lab personnel next year as it intensifies its R&D activities. As a result of the latest positions created, LXRP is issuing 240,000 new stock options with an exercise price of $1.06 that will vest as to 80,000 per year until April 15, 2021, it announced.

Based in British Columbia, Canada, LXRP is a biotechnology company that out-licenses its disruptive delivery technology that promotes healthier ingestion methods. LXRP holds a patent for oral delivery of all cannabinoids and has a growing IP portfolio. DehydraTECH is its proprietary absorption technology platform.

LXRP has received $110,000 from exercised warrants (http://ibn.fm/9vz2Y). The company has also received for exercise a total of 250,000 previously granted warrants with an exercise price of $0.44. Proceeds will be used for general corporate purposes, the company said. No commissions or placement fees were paid related to the funds received from these warrants. LXRP added that the warrants were exercised by third parties, not officers or directors of the company.

For more information, visit the company’s website at www.LexariaBioscience.com

• The safety of a novel combined advanced breast cancer treatment has proven to be excellent, BriaCell announced at a major breast cancer conference
• The monotherapy (i.e. drug on its own) clinical trial showed positive anti-tumor activity in patients with advanced breast cancer and metastases
• Further information about the efficiency of the Bria-IMT/KEYTRUDA combined treatment will be provided in the first quarter of 2019

Initial data from a combination study of Bria-IMT and KEYTRUDA (pembrolizumab) demonstrated an excellent safety profile, BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) announced at the 2018 San Antonio Breast Cancer Symposium (http://ibn.fm/ehRA0). During the conference, the immuno-oncology focused biotechnology company also presented positive proof of concept data for Bria-IMT as a monotherapy for the treatment of advanced breast cancer.

“The robust biological activity of Bria-IMT demonstrated through the trials is very exciting,” BriaCell’s president and CEO, Dr. William Williams, said in a news release. “The findings also reinforce the product development strategy for Bria-OTS – BriaCell’s off-the-shelf personalized immunotherapy solution.”

Studies so far have demonstrated the ability of Bria-IMT to promote a powerful immune response that causes tumor regression in patients with advanced stage breast cancer. “We are highly confident of our strategy to use Bria-IMT in combination with KEYTRUDA, an approved treatment for multiple cancer indications, and expect synergistic activity of this combination in patients with advanced breast cancer. We look forward to additional clinical data and expect to share details at upcoming scientific meetings,” Dr. Williams added.

Presenting the poster was Saveri Bhattacharya (http://ibn.fm/k4uAG), DO, assistant professor of medical oncology at Thomas Jefferson University (http://ibn.fm/fVi7N), researcher at the NCI-designated Sidney Kimmel Cancer Center (http://ibn.fm/2T9hs) at Jefferson Health (http://ibn.fm/7nxXg) and principal investigator (PI) of the study.

In the combination therapeutic study, five patients were treated with Bria-IMT and Merck & Co., Inc.’s (NYSE: MRK) KEYTRUDA. The combination was tolerated very well, and the study is still ongoing to provide further data on the safety of the therapeutic approach. More information about the efficacy of the combination is to be presented in the first quarter of 2019.

Additionally, examination of Bria-IMT’s efficacy in the treatment of advanced breast cancer is ongoing. The Bria-IMT phase I/IIa monotherapy study involved 23 patients who were very heavily pre-treated (a median of four previous systemic therapy regiments per patient). The treatment with Bria-IMT was well-tolerated, with minor local irritation at the injection site being reported as the most common adverse effect.

More importantly, Bria-IMT contributed to tumor shrinkage in three of the patients. The top respondent previously received seven rounds of chemotherapy and had tumor metastases at various sites. The patient’s three-month follow-up showed shrinkage in all 20 metastatic formations in the lungs. After six months, the response was still maintained. Two other patients also showed tumor reduction. All of the patients with tumor reduction matched Bria-IMT at one or more HLA types, validating BriaCell’s approach to selecting patients most likely to respond (BriaDx). Biological activity was observed in several other of the patients, and there was a noted decrease in circulating cancer-associated cells.

Bria-IMT works by stimulating T-cell activity. T-cells are an important immune response component, and their activation is expected to increase the body’s natural ability to recognize and destroy cancer cells.

BriaCell is also focusing on the development of Bria-OTS – a personalized immunotherapy solution that matches the needs of the patient without a specialized manufacturing process. This personalized treatment is expected to be safe and highly effective while avoiding the high costs of creating personalized treatments for advanced cancer patients. In addition, Bria-OTS is created to produce a selective immune response that’s tailored to the specific needs of the cancer patient. Bria-OTS is expected to cover approximately 90 percent of the patient population.

For more information, visit the company’s website at www.BriaCell.com

• Global legal marijuana market to reach $146.4 billion by 2025
• Aeroponic systems produce higher quality at lower cost
• Green has low-cost aeroponic cannabis cultivation system

The global cannabis market is proving to be a precocious new kid on the block. In 2010, respected Harvard economist Jeffery Miron conservatively estimated the U.S. marijuana market to be around $14 billion. Back then, just 11 states – Arizona, California, Hawaii, Michigan, Montana, Nevada, New Jersey, New Mexico, Rhode Island, Vermont and Washington – had legalized medical marijuana, and no state had legalized adult recreational use. However, in April 2018, a report from Grand View Research estimated that the value of the global legal marijuana market – medical and recreational – would reach $146.4 billion by the end of 2025 (http://ibn.fm/7Ylht). Such growth, if realized, would certainly merit the marker of maturity. As the market grows and competition intensifies, efficiency in cultivation and production methods will be a crucial aspect of the value chain, making cost-effective grow solutions like those offered by Green Hygienics Holdings Inc. (OTC: GRYN) increasingly important.

Green Hygienics is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational markets. Its strategy revolves around hygienics, the science of preserving and promoting the health of individuals, communities and the planet. Green Hygienics entered the commercial indoor cultivation industry in 2015 and is currently seeking contracts to build marijuana-growing operations utilizing aeroponics, the optimal method for cultivating cannabis.

Essentially, there are three distinct methods of indoor cultivation. For flowers and shrubs, peat-based soil mixtures for roots are best. For wet-weight produce, such as tomatoes, peppers and cucumbers, hydroponics, where the roots are immersed in nutrient-rich liquids, is ideal. However, for dry-weight produce, such as leafy greens, herbs and cannabis, aeroponics, where the roots hang in air permeated by a mist of nutrients, is best. This is Green Hygienics’ forte. The company has developed expertise in aeroponics, and its proprietary aeroponics cultivation system provides a direct feed to plant roots in an enclosed system. A centralized monitoring system ensures that the right temperature and the optimal mix of nutrients is delivered continuously and consistently to plants. This results in benign growing conditions, superior quality and superior yields.

There are many advantages to aeroponics systems. Since they operate in a controlled, protected environment, they escape attack from pests and contamination from toxic agents. In addition, they typically enable faster growth, higher yields and superior quality; are easily scalable; and provide crops that are easier to harvest. They also reduce labor cost, costs of nutrients, grow area and water requirements. Through Green Hygienics’ earlier acquisition of some very important technology, the company has the capacity to become a low-cost producer. Its production cost per gram is estimated to be under $1, while direct competitors cultivating a higher-end indoor product will generally have costs in the range of $2 to $4.

Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems with the objective of providing the medical and recreational markets with the best possible product and experience. The company aims to grow by generating revenues from the cultivation and sales of premium grade cannabis and derived products, developing and licensing valuable intellectual property assets, making strategic acquisitions and creating trusted global consumer brands.

For more information, visit the company’s website at www.GreenHygienicsHoldings.com

• Net Element recognized as Payment Solutions Provider of the Year and Scale-up Company of the Year (Payment Solutions) by industry leaders
• Company CEO Oleg Firer received news magazine ACQ5’s ‘Gamechanger of the Year’ award
• Net Element’s quarterly report shows growing revenues as company provides specialized payment solutions to varied industries

Mobile payment technology innovators at Net Element, Inc. (NASDAQ: NETE) were recognized for their visionary approach to the global payment services industry this month when international corporate magazine news site ACQ5 announced its annual Global Awards (http://ibn.fm/ykmUB) honoring companies “whose activities set the standard for their markets.”

Net Element, a Miami, Florida-based company with global reach, was honored as ‘Payment Solutions Provider of the Year’ for the Americas and ‘Scale-up Company of the Year (Payment Solutions)’ for the Americas. Net Element CEO Oleg Firer was honored as ‘Gamechanger of the Year’ for the Americas.

“Our goal at Net Element is to be exactly as represented by the award we won — a gamechanger for the payments services industry by providing our merchants with seamless multi-channel payment solutions, value added services and creating value for our shareholders,” Firer stated in a news release recognizing the honors (http://ibn.fm/4YPlI).

ACQ5 is an English-language magazine news portal for corporate executives that boasts 168,000 subscribers and is in its 13th year of recognizing industry leaders through its Global Awards, which draw on readers’ insight and experience during the nomination process to return a graded analysis of companies’ market performance, responsiveness, value for money and experience.

Net Element’s VIP Payments solution supports hotel and tourism industry enterprises with specialized payment procession technology (http://ibn.fm/59BA0). Its subscription-based, online solution supports the e-commerce and B2B networking needs of brick and mortar businesses (http://ibn.fm/H86rR). The company’s Aptito program serves the restaurant industry (http://ibn.fm/KYJQH), and its Unified Mobile Payments division is catered to the needs of the kiosk and truck vendor market (http://ibn.fm/j4yc9).

Net Element is also positioned as the only Nasdaq-listed U.S. company ready to benefit from growth in electronic payment services in Russia, thanks to its partnership with Sputnik Bank to offer third-party bank processing to other banking institutions throughout the country (http://ibn.fm/0G0go). Russian banks have relied on personal, in-house systems that are showing their age as they continue to operate on technological standards established in the wake of the Soviet Union’s dissolution in the early 1990s.

The company’s quarterly report, issued on November 14, noted year-over-year revenue growth of $2.3 million for the most recent quarter and nearly $5 million in year-to-date growth. Operating expenses remained flat (http://ibn.fm/tunsc). At an annual meeting of the company on November 27, stockholders approved an amendment to the company’s 2013 Equity Incentive Plan to increase the number of available common stock shares by 178,900 in order to attract new investment with a long-term outlook for the company (http://ibn.fm/3Evs3).

For more information, visit the company’s website at www.NetElement.com

• Uses heat and light energy to provide non-invasive and pain-free skin care
• InterceptCS™ provides cold sore prevention with controlled topical heat
• TherOZap™ relieves symptoms caused by insect and marine life bites and stings, holds potential for inhibiting mosquito-borne viruses
• A third product is in development to treat joint pain through the combination of cannabis and thermal technology

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a progressive medical device technology company focused on serving the $21 billion cosmeceutical industry by providing products, devices and treatments that address dermatological needs. The company believes that clear and healthy skin should not be a privilege for those who can afford costly procedures and treatments, but rather a possibility that is accessible for all.

Heat and light energy are used by ThermaBright to provide non-invasive and pain-free skin care. This proprietary technology has received Class II medical device status from the U.S. Food and Drug Administration. Patent and trademark protection have also been initiated for products developed to incorporate medicinal cannabis into the use of the company’s thermal therapy tech.

InterceptCS is ThermaBright’s cold sore prevention device*. This device treats cold sores at their earliest appearance through the application of topical thermal technology with no risk of burning the skin. Used at the first sign of a cold sore, InterceptCS can prevent further symptoms from developing by killing cells that have been infected by the herpes simplex Type 1 virus.

The market potential for InterceptCS is high, with a reported 20-40 percent of the Canadian and United States population experiencing recurrent cold sore outbreaks. No prescription to use this device is required, making it more accessible to a larger market. Plans are in place to bring various models to market beyond the current single-use activator, further elevating the value for the customer.

Another of ThermaBright’s revolutionary products is TherOZap. This device uses thermal therapy as a second line of defense against insect bites. The device is used to relieve the pain, itch and swelling that can result from more than 20,000 types of insect and marine life bites and stings. These includes bees, wasps, hornets, mosquitos, black flies and jellyfish. Plans are in place to test the technology’s effectiveness in inhibiting mosquito-borne diseases such as the Zika and Dengue viruses.

A third product is in the works for a new pain relief device. This novel device is for the relief of back, knee or other joint pain. It combines the company’s thermal therapy tech with medical grade cannabis or cannabidiol (CBD) used as a cream or gel.

In preparation for this unique device, ThermaBright is in the process of creating a wholly owned subsidiary, according to a recent press release (http://ibn.fm/5ySjg). The company has indicated that an acquisition will be sought to further the development of this new product. The cannabis related device acquisitions, along with any products created, will be held in this new subsidiary.

For more information, visit the company’s website at www.ThermaBright.com

• Based on double blind placebo study the InterceptCS™ is approved for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” by Health Canada. The InterceptCS™ is not approved by the United States FDA for any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

• Sharing Services utilizes the direct selling channel to produce 100 percent organic growth
• The company continues to promote its Blue Ocean Strategy
• Sharing Services is currently introducing its products in select Canadian provinces
• Company continues to experience steady growth in sales volume and assets reported

A diversified holding company based in Plano, Texas, Sharing Services, Inc. (OTCQB: SHRV) specializes in the direct selling industry. The company leverages a Blue Ocean Strategy, which combines diverse keys together to implement Sharing Services’ vision. These keys include elevating home-based entrepreneurs (Elepreneurs) and using the direct selling channel to generate 100 percent organic growth.

Sharing Services is experiencing substantial sales increases this year (http://ibn.fm/9lIte). As of July 2018, the company’s sales volume was $12.93 million. On November 2, 2018, Sharing Services held its annual shareholder meeting in Atlanta, Georgia. This meeting was before the opening of the third major conference for its subsidiary, Elepreneurs, LLC (http://ibn.fm/X2o2Q).

Elepreneurs, LLC is a 100 percent wholly owned subsidiary of Sharing Services. Its particular structure is focused on contracting with companies to promote and sell products through a direct selling model. In 2017, 18.6 million people were involved in direct selling in the U.S. – the world’s largest direct selling market (http://ibn.fm/2PkWT). One reason for this significant involvement is that direct selling provides accommodating hours, as well as entrepreneurial opportunities to all age groups.

Sharing Services owns, operates or controls an interest in an array of companies specializing in the direct selling industry. These companies either sell products to the consumer directly, via independent representatives, or provide offerings ranging from health and wellness, energy, technology and insurance services to training, media and travel benefits.

Sharing Services is working to mesh Eleprenuers with the Sharing Service brand to create mutual benefits. Elevating home-based entrepreneurs, called Elepreneurs, is a primary emphasis of the company. Sharing Services is utilizing the direct selling channel to produce 100 percent organic growth. The goal is to create as many successful, independent business leaders as possible. In the last few months, the company has grown by 10,000 independent sales representatives.

Sharing Services also has its new Elevacity Global product. Elevacity offers patented nutritional consumer products and virtual success training – all integrated with an innovative rewards program. The Elevacity Brand consists of core products in the nutritional beverage category, supplements and unique skin care offerings (http://ibn.fm/66P5s). Products include Elevate Brew, XanthoMax (a flavonoid), and Choclevate (a Nootropic Hot Chocolate), among others.

Recently, the company announced that its wholly-owned Elevacity Global subsidiary will launch its line of nutraceutical products in the Canadian provinces of Ontario and British Columbia. Presently, it is awaiting approvals for enrollment opportunities in all other Canadian provinces (http://ibn.fm/jwgZD).

The Elevacity Global brand undergoes distribution through the Elepreneurs independent sales team. Elepreneurs continue to promote the company’s Blue Ocean Strategy philosophy globally.

In a news release, John “JT” Thatch, chief executive officer of Sharing Services, stated, “We have placed a concentrated effort to complete the regulatory process in Canada over the past several months and are excited to start processing orders and quickly fulfill consumer demand in those provinces.”

Re-configuring how entrepreneurs succeed, Sharing Services continues to innovate with products and the direct selling model. The company’s dedication is to sharing its collective products and services by way of home-based Elepreneurs. Sharing Services offers opportunities to creative entrepreneurs and shareholders alike.

For more information, visit the company’s website at www.SHRVinc.com